In a 13-year-old boy with a 10‑day history of intermittent headache and on‑and‑off fever, now presenting with new chest pain and headache and a Glasgow Coma Scale of 15, what is the likely diagnosis and recommended treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2

This 13-year-old boy with 10 days of intermittent headache, on-and-off fever, and new-onset chest pain most likely has Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2, and requires immediate hospitalization with urgent diagnostic workup including SARS-CoV-2 testing, cardiac evaluation, and inflammatory markers.

Clinical Reasoning

The constellation of symptoms—prolonged intermittent fever (10 days), headache, and new chest pain in an adolescent—strongly suggests MIS-C, which typically emerges 2-6 weeks after peak COVID-19 incidence in a geographic area 1. MIS-C commonly affects children with a broader age range than typical Kawasaki disease, with increased incidence in adolescents, and frequently presents with prominent neurological symptoms (severe headache, altered mental status) and cardiac involvement (chest pain, myocardial dysfunction) 1.

The neurological symptoms (persistent headache) combined with cardiac symptoms (chest pain) are particularly concerning features of MIS-C. The guideline explicitly notes that "increasing reports of neurologic involvement, manifesting as severe headache, altered mental status, cranial nerve palsies, or meningismus" occur in select MIS-C patients 1. The chest pain likely represents cardiac involvement, which is a hallmark of MIS-C.

Immediate Diagnostic Workup

Tier 1 Screening (Send Immediately):

  • Complete blood count (CBC) - looking for lymphopenia, thrombocytopenia
  • Complete metabolic panel (CMP) - checking sodium, liver enzymes
  • ESR and CRP - typically markedly elevated in MIS-C
  • SARS-CoV-2 PCR and serology (IgG, IgM, IgA if available) 1

Tier 2 Evaluation (If Tier 1 Suggests MIS-C):

  • Troponin T and BNP - assess cardiac involvement
  • Procalcitonin - if available
  • D-dimer, ferritin, fibrinogen - markers of inflammation and coagulopathy
  • ECG - assess for cardiac conduction abnormalities
  • Echocardiography - evaluate for myocardial dysfunction, coronary artery abnormalities 1

Key Laboratory Thresholds Suggesting Severe Disease:

  • ESR >240 mm/hour
  • Platelet count <150,000/µL
  • Absolute lymphocyte count <1,000/µL
  • Sodium <135 mmol/L 1

Treatment Protocol

Immediate Management:

  1. Hospitalization - All suspected MIS-C cases require admission for close monitoring
  2. Supportive care - IV fluids, oxygen if needed, cardiac monitoring
  3. Avoid empirical antibiotics initially unless bacterial infection cannot be excluded

Immunomodulatory Therapy (Once MIS-C Confirmed):

Based on the 2020 ACR guidance 1, treatment typically includes:

  • Intravenous immunoglobulin (IVIG): 2 g/kg as single dose (or divided over 2 days if volume concerns)
  • Corticosteroids: Methylprednisolone 1-2 mg/kg/day, particularly if:
    • Severe cardiac dysfunction
    • Shock requiring vasopressor support
    • Inadequate response to IVIG alone

The guideline achieved moderate-to-high consensus that both IVIG and corticosteroids are effective in MIS-C 1.

Critical Differential Diagnoses to Exclude

1. Bacterial Meningitis/Encephalitis

While the GCS is 15/15 (reassuring), persistent headache with fever warrants consideration. However, the 10-day duration with intermittent symptoms and lack of meningismus makes acute bacterial meningitis less likely. If any concern exists, lumbar puncture should be performed before starting immunosuppression 2.

2. Myocarditis (Non-MIS-C)

Viral myocarditis can present with chest pain and headache 3. However, the prolonged 10-day course with intermittent fever is more consistent with MIS-C than acute viral myocarditis, which typically presents more acutely 3.

3. Influenza with Complications

The pandemic flu guidelines describe neurological complications of influenza including encephalitis 4. However, the 10-day duration and chest pain make MIS-C more likely. If influenza is suspected, oseltamivir should be considered, though benefit beyond 48 hours of symptom onset is limited 4.

4. Mycoplasma pneumoniae Encephalitis

M. pneumoniae can cause encephalitis with headache, fever, and respiratory symptoms in older children (median age 11 years) 2, 5. However, the chest pain and cardiac symptoms point more toward MIS-C. Consider M. pneumoniae serology if respiratory symptoms are prominent.

Common Pitfalls to Avoid

  1. Dismissing as viral illness: The 10-day duration with new symptoms (chest pain) should raise red flags. Simple viral illnesses typically improve by day 5-7 6.

  2. Delaying cardiac evaluation: Chest pain in the context of MIS-C can indicate myocarditis or coronary artery involvement. Troponin and echocardiography should not be delayed 1.

  3. Missing SARS-CoV-2 link: Many MIS-C patients have negative PCR but positive serology, indicating recent infection. Send both tests 1.

  4. Starting antibiotics prematurely: Unless bacterial infection is strongly suspected, avoid antibiotics that may confound the clinical picture. MIS-C is immune-mediated, not infectious 1.

  5. Underestimating neurological involvement: Severe headache in MIS-C can indicate meningismus or encephalopathy. Monitor closely for deterioration in mental status 1.

Monitoring and Follow-up

  • Continuous cardiac monitoring for arrhythmias
  • Serial troponin and BNP every 12-24 hours initially
  • Repeat echocardiography at 1-2 weeks and 4-6 weeks to assess for evolving coronary artery abnormalities
  • Neurological checks every 4 hours for first 24-48 hours
  • Inflammatory markers (CRP, ESR) to guide treatment duration

The temporal association with SARS-CoV-2 (typically 2-6 weeks post-infection), the age of the patient (13 years), the combination of neurological and cardiac symptoms, and the prolonged fever pattern all strongly support MIS-C as the primary diagnosis 1.

References

Related Questions

In a previously healthy 12-year-old boy who experienced a single diffuse headache with vomiting lasting about one hour, followed by two hours of sleep and no further episodes, what is the appropriate management and follow‑up?
In a 13‑year‑old on day 6 of the febrile phase of dengue with severe thrombocytopenia, leukopenia, normal hematocrit, brief upper‑extremity stiffening (possible seizure) without loss of consciousness, minimal hematemesis, stable blood pressure, and adequate urine output while receiving hydration, what is the appropriate immediate management?
What is the appropriate emergency evaluation and management for a 13-year-old male with new-onset headache, a brief episode of transient total visual loss while stretching, persistent headache, and tinnitus?
What is the appropriate management of central (neurogenic) fever in a patient after subdural hematoma evacuation?
What are the likely causes of headache, dyspnea, and abnormal movements in a 13-year-old child?
Can selective serotonin reuptake inhibitors (SSRIs) increase the risk of new-onset suicidal ideation in a patient with no prior history of suicidal thoughts?
Could an occlusive thrombus in the proximal-to-mid right gastrocnemius muscle cause a stroke, or are the mechanisms separate?
What should be done for a ventilator‑dependent patient with Duchenne muscular dystrophy who cannot maintain cuff inflation and has low returned ventilator volumes?
What is the recommended assessment and management approach for menopause and perimenopause in primary care for a woman in her mid‑40s to early‑50s?
What is the most effective over‑the‑counter (OTC) steroid cream for treating an anal fissure in an adult without known allergy, infection, or immunosuppressive condition?
What are the recommended dosing, monitoring, contraindications, and alternative agents for using dexmedetomidine for procedural sedation or as an adjunct to general anesthesia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.